undamentalytics Newsletter
Sign in

Imagenebio, Inc. revenue

Imagenebio, Inc.'s revenue was $800,000 in fiscal 2025, down 77.1% on the year before. Since fiscal 2020 ($9.2m) it has grown at a compound -38.6% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue93116941
Growth on the year before—+237.0%−49.6%−41.3%−61.8%−77.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Imagenebio, Inc. $800,000 -41.3% -58.0%
Medicinova Inc $920,481 875.7% —
Shattuck Labs, Inc. $1.0m -66.6% 5.2%
Longeveron Inc. $1.2m -42.7% 10.4%
Cardiff Oncology, Inc. $508,000 -7.0% 7.2%
Dare Bioscience, Inc. $1.4m 4366.5% —

Compare with peers

Head to head: IMA vs MNOVIMA vs STTKIMA vs LGVN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Imagenebio, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Imagenebio, Inc.